Investigation of the Safety and Effectiveness of a Trifocal IOL

NACompletedINTERVENTIONAL
Enrollment

539

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

May 13, 2024

Study Completion Date

May 13, 2024

Conditions
Eye DiseasesPostcataract AphakiaCataractLens Opacities
Interventions
DEVICE

FINEVISION HP IOL

Cataractous lens will be removed in the study eyes and the FINEVISION HP IOL will be implanted in the capsular bag.

DEVICE

Alcon AcrySof SN60AT

Cataractous lens will be removed in the study eyes and the Alcon AcrySof SN60AT IOL will be implanted in the capsular bag.

Trial Locations (20)

15122

Associates in Ophthalmology Ltd, West Mifflin

24502

Piedmont Eye Center, Lynchburg

44141

Cleveland Eye Clinic, Brecksville

46240

Michael Washburn Center for Ophthalmic Research, Indianapolis

55420

Chu Vision Institute, Bloomington

56308

Vance Thompson Vision, MN Site, Alexandria

57108

Vance Thompson Vision. SD Site, Sioux Falls

58078

Vance Thompson Vision ND Site, West Fargo

59718

Vance Thompson Vision, MT Site, Bozeman

60467

Arbor Centers for Eye Care, Orland Park

63131

Ophthalmology Consultants, Ltd, St Louis

68137

Vance Thompson Vision NE Site, Omaha

75243

Key-Whitman Eye Center, Dallas

75965

Lehmann Eye Center, Nacogdoches

78229

Parkhurst Nuvision, San Antonio

84107

The Eye Institute of Utah, Salt Lake City

89145

Center For Sight, Las Vegas

91325

Mitchell C Shultz MD/Shultz Chang Vision, Northridge

92868

Coastal Vision Medical Group, Orange

08361

Eye Associates & SurgiCenter, Vineland

All Listed Sponsors
lead

Beaver-Visitec International, Inc.

INDUSTRY